8-K//Current report
SAB Biotherapeutics, Inc. 8-K
Accession 0000950170-25-096645
$SABSCIK 0001833214operating
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:00 PM ET
Size
209.2 KB
Accession
0000950170-25-096645
Documents
- 8-Ksabs-20250717.htmPrimary
8-K
- EX-101.SCHsabs-20250717.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-096645-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLsabs-20250717_htm.xml
IDEA: XBRL DOCUMENT
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001833214
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:00 PM ET
- Size
- 209.2 KB